All NucliSENS assays and kits give your laboratory standarization without loss of flexibility, sensitivity geared to your requirements and high reliability for routine diagnosis.

NucliSENS^® HIV-1 QT
bioMerieux has obtained FDA approval of our PMA for the NucliSENS HIV-1QT, an in vitro nucleic acid test for the quantitation of HIV-1 RNA in human plasma. The performance and outstanding reliability of the HIV-1 QT assay make it the ideal test for routine patient viral load monitoring.
Click here for more information

NucliSENS^® HIV-1
A qualitative research-use-only assay for detecting HIV-1 RNA, making it ideal for HIV transmission studies.

NucliSENS^® CMV pp67
An FDA-cleared qualitative assay to detect active CMV infection in immunosuppressed individuals such as HIV-infected and transplantation patients. NucliSENS CMV pp67 directly and objectively determines whether viral replication is occuring in a patient and is consequently ideally suited to guide antiviral therapy.
Click here for more information

NucliSENS^® Basic Kit
An open assay platform for setting up RNA amplification assays for routine use. The kit contains all quality-controlled reagents and standardized procedures for RNA release, isolation, amplification and detection. Assays can be set up easily using protocols from the Basic Kit website and ordering of the amplification primers and capture probe at your preferred oligo supplier. Alternatively, you can choose to develop a new assay with the support of bioMérieux researchers.
Click here for more information

NucliSENS^® Isolation Kit
A separate kit for highest-quality extraction of total nucleic acid from a variety of sample types. The extract can be used as input for any amplification and sequencing technology.
Click here for more information